Objectives: to explore the experiences of people with Motor Neurone Disease (MND), current and bereaved carers in the final stages of the disease and bereavement period.
Methods: a qualitative study using narrative interviews was used to elicit accounts from 24 people with MND and 18 current family carers and 10 former family carers.
Results: the needs of patients and carers are not being adequately met in the final stages of MND and there appears a need for increased, co-ordinated support from palliative care services. The use of advance care planning tools is regarded as beneficial for patients and carers, but health professionals demonstrate a limited understanding of them. Anxiety and distress in patients, carers and bereaved carers is heightened during this period. Carer burden is excessive and may exacerbate patient distress and desire for hastening death.
Conclusion: this study has identified a number of issues people with MND and their carers face in the final stages of the illness, indicating some ways in which health, social and palliative care services could be improved or co-operate more effectively in order to better meet their needs.
TalbotKMarsdenR. Motor Neurone Disease; the facts. Oxford: Oxford University Press, 2008, p.1.
3.
GanziniLJohnstonWSHoffmanWF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology1999; 52: 1434.
4.
MandlerRNAndersonFAMillerRGClawsonLCudkowiczMDel BeneM. The ALS patient care database: insights into end-of-life care in ALS. Amyotroph Lateral Scler2001; 2: 203–208.
5.
BorasioGDVoltzR. Palliative care in amyotrophic lateral sclerosis. Neurology1997; 244(Suppl 4): S11–S17.
6.
GanziniLJohnstonWSSilveiraMJ. The final month of life in patients with ALS. Neurology2002; 59: 428–431.
7.
BaumruckerS. Palliative care in Amyotrophic Lateral Sclerosis: a new tool in the fight against an old enemy. Am J Hosp Palliat Care2001; 18: 81–82.
8.
ElmanLBHoughtonDJWuGFHurtigHIMarkowitzCEMcCluskeyL. Palliative care in amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis. J Palliat Med2007; 10: 433–457.
9.
McCluskeyL. Palliative rehabilitation and Amyotrophic Lateral Sclerosis: a perfect match. NeuroRehabilitation2007; 22(6): 407–408.
10.
OliverDWebbS. The involvement of specialist palliative care in the carer of people with motor neurone disease. Palliat Med2000; 14: 427–428.
11.
BarbyTFMLeighPN. Palliative care in motor neurone disease. Int J Palliat Nurs1995; 1: 183–188.
12.
AlbertSMMurphyPLDel BeneMLRowlandLP. Prospective study of palliative care in ALS: choice, timing, outcomes. J Neurol Sci1999; 169: 108–113.
13.
HicksFCorcoranG. Should hospices offer respite admission to patients with motor neurone disease?Palliat Med1993; 7: 145–150.
14.
KristjansonLJToyeCDawsonS. New dimensions in palliative care: a palliative approach to neurodegenerative diseases and final illness in older people. Palliat Care2003; (Suppl 179): S41–S43.
15.
GoyERCarterJGanziniL. Neurologic disease at the end-of-life: caregiver descriptions of Parkinson’s disease and Amyotrophic Lateral Sclerosis. J Palliat Med2008; 11: 548–554.
16.
McKennaCMcLeodR. Access to palliative care for people with motor neurone disease in New Zealand. J New Zeal Med Assoc2005; 118: 122.
17.
BolmsjoIHermerenG. Interviews with patients, family and caregivers in Amyotrophic Lateral Sclerosis: comparing needs. J Palliat Care2001; 17: 236–240.
18.
BolmsjoIHermerenG. Conflicts of interest: experiences of close relatives of patients suffering from amyotrophic lateral sclerosis. Nurs Ethics2003; 10: 186–198.
19.
DawsonSKristanjonL. Mapping the journey: family carers’ perceptions of issues related to end-stage care of individuals with muscular dystrophy or motor neurone disease. J Palliat Care2003; 19: 1.
20.
HerzHMcKinnonPButowP. Proof of live and other themes: a qualitative exploration of the experience of caring for people with motor neurone disease. Progr Palliat Care2006; 14: 209–214.
21.
Addington- HallJ. Research sensitivities to palliative care patients. Eur J Canc Care2002; 11: 220–224.
22.
Department Of Health. End-of-life care strategy – promoting high quality care for all adults at the end-of-life. London: The Stationery Office, 2008.
23.
Department of Health. Research governance framework for health and social care. London, DoH. 2nd ed.2005.
24.
UsherKJArthurRN. Process consent: a model for enhancing informed consent in mental health nursing. Journal of Advanced Nursing1998; 27(4): 692–697.
25.
OvercashJ. Narrative research: a review of methodology and relevance to clinical practice. Crit Rev Oncol Hematol2003; 48: 179–184.
26.
BrownJBAddington- HallJ. How people with motor neurone disease talk about living with their illness: a narrative study. J Adv Nurs2008; 62: 200–208.
27.
LocockLBrownJB. All in the same boat? Patient and care attitudes to peer support and social comparison in Motor Neurone Disease, (MND). Soc Sci Med2010; 71: 1498–1505.
28.
Attride-SterlingJ. Thematic networks: an analytic tool for qualitative research. Qual Res2001; 1: 385–405.
29.
BraunVClarkeV. Using thematic analysis in psychology. Qual Res Psychol2006; 3: 77–101.
GanziniLJohnstoneWSMcFarlandBHTolleSLeeMA. Attitudes of patients with Amyotrophic Lateral Sclerosis and their caregivers toward assisted suicide. New Engl J Med1998; 339: 967–973.
32.
EmanuelLLBarryMJStoeckleJDEttelsonLMEmanuelEJ. Advance directives for medical care: a case for greater use. New Engl J Med1991; 324: 889–894.
33.
BendittJOSmithTSTonelliMR. Empowering the individual with ALS at the end-of-life: discourse specific advance care planning. Muscle Nerve2001; 24: 1706–1709.
34.
TenoJMLynnJPhillipsRSMurphyDYoungnerSJBellamyPAFJr. Do formal advance directives affect resuscitation decisions and the use of resources for seriously ill patients?J Clin Ethics1994; 5: 23–30.
35.
HughesRAAspinalFHigginsonIJAddington-HallJDunckleyMFaullC. Assessing palliative care outcomes for people with motor neurone disease living at home. Int J Palliat Nurs2004; 10: 449–453.
36.
StoreyLCallagherPMitchellDAddison-JonesRBennettW. Extending choice over where to receive end-of-life care to motor neurone disease patients. Br J Neurosci Nurs2006; 2: 2–7.
37.
PrestonHCohen FinebergICallagherPMitchellJDM. The Preferred Priorities for Care document in Motor Neurone Disease: views of bereaved relatives and carers. Palliat Med2011; 25(4): 1–7.
38.
SilaniVBorasioGD. Honesty and hope: announcement of diagnosis in ALS. Neurology1999; 53: S37–S39. Discussion S40-S42.
39.
HowardRSOrrellRW. Management of MND. Postgrad Med J2002; 78: 736–741.
40.
MartinJTurnballJ. Lasting impact in families after death from ALS. Amyotroph Lateral Scler2002; 2: 181–187.
41.
HebertRSLacomisDEasterCFrickVShearMK. Brief communications: grief support for informal caregivers of patients with ALS: a national survey. Neurology2005; 64: 137–138.
42.
LeighPNAbrahamsSAl-ChalabiAAmpongM-AGoldsteinLHJohnsonJ. The management of motor neurone disease. J Neurol Neurosurg Psychiatr2003; 74(Suppl 4): iv32–iv47.
43.
SullivanADHedbergKHopkinsD. Legalized physician-assisted suicide in Oregon. New Engl J Med2001; 344: 605–607.
44.
KellyBBurnettPPelusiDBadgerSVargheseFRobertsonM. Factors associated with the wish to hasten death: a study of patients with terminal illness. Psychol Med2003; 33: 75–81.
45.
ChioAGauthierACalvoAGhigionePMutaniR. Caregiver burden and patients’ perception of being a burden in ALS. Neurology2005; 64: 1780–1782.
46.
HechtMJGraeselETiggersS. Burden of care in Amyotrophic Lateral Sclerosis. Palliat Med2003; 17: 327–333.
47.
MacleodJEClarkeDM. A review of psychosocial aspects of motor neurone disease. J Neurol Sci2007; 258: 4–10.
48.
BreitbertWRosenfeldBPessinHKaimMFunesti-EschJGaliettaM. Depression, hopelessness and desire for hastened death in terminally ill patients with cancer. J Am Med Assoc2000; 284: 2907–2911.
49.
EdelmanSKidmanAD. Application of cognitive behaviour therapy to patients who have advanced cancer. Behav Change2000; 17: 103–110.
50.
BeaverKLukerKWoodsS. Conducting research with the terminally ill: challenges and considerations. Int J Palliat Nurs1999; 5: 13–17.
51.
LeadbeaterCGarberJ. Dying for change. London: Demos, 2010.
52.
Department of Health. End of life care in long term neurological conditions; a framework for implementation. London, NEoLCP. 2010.
